| Cat.No. | Name | Information |
|---|---|---|
| M2206 | TH-302 (Evofosfamide) | TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM. |
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M21100 | WX-081 | WX-081, an anti-tuberculosis agent (anti-tuberculosis), has excellent anti-mycobacterial activity against M. tuberculosis H37Rv. It is an oral mycobacterial ATP synthase inhibitor under development for the study of tuberculosis (TB). |
| M21096 | TXA6101 | TXA6101 is a filamentous temperature-sensitive mutant Z (FtsZ) protein inhibitor. TXA6101 has an antibacterial activity MIC value of 1 μg/mL against MRSA isolates expressing either G193D or G196S mutant FtsZ, retaining significant activity against the TXA707-resistant FtsZ mutant. It is being developed for use against Gram-negative bacteria. |
| M21091 | DS69910557 | DS69910557 is an oral parathyroid hormone (PTH) type 1 receptor (PTHR1) inhibitor that is being developed as a hypercalcemic compound. |
| M21090 | ITI-214 free base | ITI-214 free base is a potent inhibitor of CNS activity and an orally bioactive PDE1 inhibitor (Ki of 58 pM) with good selectivity for other PDE family members and a range of enzymes, receptors, transporters and ion channels. |
| M21066 | GCC5694A | GCC5694A is an oral SGLT2 inhibitor. SGLT2 inhibitors help people with diabetes control their blood sugar by preventing glucose reabsorption in the kidneys. |
| M21065 | BMS-820132 | BMS-820132 is an oral glucokinase (GK) partial activator for the study of diabetes mellitus. the AC50 is 29 nM. |
| M21064 | Bradanicline | Bradanicline (ATA-101; TC-5619) is a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist (EC50=17 nM for human α7 nAChR; Ki=1.4 nM). Bradanicline can be used to study cognitive impairment. |
| M21063 | LEO 134310 | LEO 134310 is a non-steroidal, selective glucocorticoid receptor (GR) agonist that is being studied in the first phase of plaque psoriasis.LEO 134310 has shown high affinity (EC50 of 14 nM) in GR binding assays.LEO 134310 can be used in dermatological conditions. |
| M21062 | DS-3801b | DS-3801b is a non-mescaline GPR38 agonist, DS-3801b is expected to be a novel gastrointestinal prokinetic agent for the study of functional gastrointestinal disorders such as gastroparesis and chronic constipation. |
| M21061 | GSK3640254 | GSK3640254 is an HIV maturation inhibitor and Phase IIb clinical candidate (60-180 mg PO QD) active against a range of HIV strains with the Gag polymorphism. |
| M21056 | MK-0159 | MK-0159 is an oral CD38 inhibitor that is being developed for cardiovascular disease. |
| M21055 | TAS1553 | TAS1553 is an oral ribonucleotide reductase (RNR) inhibitor with antitumor activity. |
| M21050 | Lactobionic acid | Lactobionic acid, an α-hydroxyacid (AHA) with antioxidation activity, is used in the development of cosmeceuticals for skin. |
| M21049 | 4-Chloro-2-hydroxybenzoic acid, 4-chloro salicylic acid | 4-Chlorosalicylic acid was used in sensitive spectrofluorometric determination of terbium in mixed rare earths and preparation of poly(4-chlorosalicylic acid-formaldehyde) via condensation with formaldehyde. |
| M21048 | Methylprednisolone Acetate | Methylprednisolone (NSC-19987, Medrol) acetate is a synthetic glucocorticoid receptor agonist, used to achieve prompt suppression of inflammation. Methylprednisolone activates ACE2 and reduces IL-6 levels, thus improves severe or critical COVID-19. Methylprednisolone markedly reduces autophagy and apoptosis. |
| M21045 | 4'-Methoxychalcone | 4'-Methoxychalcone, found in citrus, is chalcone derivative that has shown diverse pharmacological properties, including anti-tumor and anti-inflammatory activities. |
| M21030 | 6-Bromo-2-hydroxy-3-methoxybenzaldehyde | 6-Bromo-2-hydroxy-3-methoxybenzaldehyde is a bromobenzaldehyde derivative that participates in the synthesis of (±)-norannuradhapurine. |
| M21027 | Calcium gluconate | Calcium gluconate is element or mineral necessary for normal nerve, muscle, and cardiac function. Calcium as the gluconate salt helps to maintain calcium balance and prevent bone loss when taken orally. |
| M21018 | Gadoxetate sodium | Gadoxetate is a paramagnetic gadolinium-containing contrast agent in which its salt form, gadoxetate disodium, is used for intravenous injection. |
| M21016 | scyllo-Inositol | scyllo-Inositol is a naturally occurring plant sugar alcohol found most abundantly in the coconut palm. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
